ExploreWatchlistsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Accounts receivable, net

Sumitomo Pharma Co., Ltd. (4506)

Market cap
¥877B
P/E ratio
9.5x
Sumitomo Pharma manufactures and sells prescription pharmaceuticals globally, with specialized focus on regenerative and cell medicine through joint ventures.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Mar 31, 202574,840-7.63%
Mar 31, 202481,023-15.52%
Mar 31, 202395,908-36.66%
Mar 31, 2022151,407+11.44%
Mar 31, 2021135,866+1.02%
Mar 31, 2020134,491+13.25%
Mar 31, 2019118,760+5.11%
Mar 31, 2018112,982+1.85%
Mar 31, 2017110,932+3.52%
Mar 31, 2016107,165+3.97%
Mar 31, 2015103,072

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat